WHAT IS RETATRUTIDE?
Retatrutide, like Semaglutide and Tirzepetide, is a peptide. However, instead of just one active receptor like Semaglutide and two active receptors like Tirzepetide, Retatrutide had 3 key activating receptors and shows promising results!
BENEFITS:
OTHER BENEFITS ASIDE FROM WEIGHT LOSS:
STUDY SIDE EFFECTS:
*All side effects improve with dose adjustment
Currently Retatrutide is in Phase 3 clinical trials. It will be re-branded and will be marketed to help patients with weight management, sleep apnea, and joint issues due to obesity. FDA is likely to approve in 2026 under the re-branded name for medication usage and cost about $1000/month.
To read more about Retatrutide clinical trial study, click here!
To be a part of the clinical study and receive Retatrutide at an extremely discounted rate, click here!